Logo image of OSUR

ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

NASDAQ:OSUR - Nasdaq - US68554V1089 - Common Stock - Currency: USD

2.99  +0.07 (+2.4%)

After market: 2.99 0 (0%)

Fundamental Rating

3

Overall OSUR gets a fundamental rating of 3 out of 10. We evaluated OSUR against 190 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for OSUR as it has an excellent financial health rating, but there are worries on the profitability. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OSUR had negative earnings in the past year.
OSUR had a positive operating cash flow in the past year.
In the past 5 years OSUR reported 4 times negative net income.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

OSUR's Return On Assets of -4.06% is fine compared to the rest of the industry. OSUR outperforms 65.79% of its industry peers.
OSUR's Return On Equity of -4.75% is fine compared to the rest of the industry. OSUR outperforms 72.11% of its industry peers.
Industry RankSector Rank
ROA -4.06%
ROE -4.75%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

The Gross Margin of OSUR (42.85%) is worse than 65.79% of its industry peers.
OSUR's Gross Margin has declined in the last couple of years.
OSUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.31%
GM growth 5Y-6.93%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSUR has been increased compared to 1 year ago.
OSUR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for OSUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

There is no outstanding debt for OSUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC8.97%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

OSUR has a Current Ratio of 9.95. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR has a Current ratio of 9.95. This is amongst the best in the industry. OSUR outperforms 92.11% of its industry peers.
OSUR has a Quick Ratio of 8.93. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR's Quick ratio of 8.93 is amongst the best of the industry. OSUR outperforms 91.58% of its industry peers.
Industry RankSector Rank
Current Ratio 9.95
Quick Ratio 8.93
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -129.55%.
OSUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.17%.
The Revenue has been growing slightly by 3.75% on average over the past years.
EPS 1Y (TTM)-129.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-151.85%
Revenue 1Y (TTM)-54.17%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-50.65%

3.2 Future

OSUR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.08% yearly.
Based on estimates for the next years, OSUR will show a decrease in Revenue. The Revenue will decrease by -2.09% on average per year.
EPS Next Y-143.23%
EPS Next 2Y-20.48%
EPS Next 3Y16.19%
EPS Next 5Y30.08%
Revenue Next Year-28.01%
Revenue Next 2Y-12.01%
Revenue Next 3Y-5.53%
Revenue Next 5Y-2.09%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OSUR. In the last year negative earnings were reported.
Also next year OSUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

95.26% of the companies in the same industry are more expensive than OSUR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.83
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

OSUR's earnings are expected to grow with 16.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.48%
EPS Next 3Y16.19%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OSUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (4/17/2025, 8:00:02 PM)

After market: 2.99 0 (0%)

2.99

+0.07 (+2.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners91.87%
Inst Owner Change0%
Ins Owners3.03%
Ins Owner Change13.78%
Market Cap231.70M
Analysts78
Price Target5.1 (70.57%)
Short Float %3.44%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-59.46%
Min EPS beat(2)-142.2%
Max EPS beat(2)23.28%
EPS beat(4)2
Avg EPS beat(4)-201.3%
Min EPS beat(4)-753.59%
Max EPS beat(4)67.32%
EPS beat(8)6
Avg EPS beat(8)6.8%
EPS beat(12)8
Avg EPS beat(12)181.89%
EPS beat(16)9
Avg EPS beat(16)99.39%
Revenue beat(2)1
Avg Revenue beat(2)0.13%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.29%
Revenue beat(4)3
Avg Revenue beat(4)1.08%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)2.18%
Revenue beat(8)7
Avg Revenue beat(8)9.07%
Revenue beat(12)11
Avg Revenue beat(12)11.98%
Revenue beat(16)14
Avg Revenue beat(16)9.76%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-173.33%
EPS NY rev (1m)-113.79%
EPS NY rev (3m)-195.24%
Revenue NQ rev (1m)-1.6%
Revenue NQ rev (3m)-11.92%
Revenue NY rev (1m)-1.16%
Revenue NY rev (3m)-8.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.25
P/FCF 9.83
P/OCF 8.46
P/B 0.56
P/tB 0.66
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)0.3
FCFY10.18%
OCF(TTM)0.35
OCFY11.81%
SpS2.4
BVpS5.3
TBVpS4.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.06%
ROE -4.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.85%
FCFM 12.69%
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.31%
GM growth 5Y-6.93%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 34.92%
Cap/Sales 2.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.95
Quick Ratio 8.93
Altman-Z N/A
F-Score6
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-151.85%
EPS Next Y-143.23%
EPS Next 2Y-20.48%
EPS Next 3Y16.19%
EPS Next 5Y30.08%
Revenue 1Y (TTM)-54.17%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-50.65%
Revenue Next Year-28.01%
Revenue Next 2Y-12.01%
Revenue Next 3Y-5.53%
Revenue Next 5Y-2.09%
EBIT growth 1Y-149.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.73%
EBIT Next 3Y45.61%
EBIT Next 5Y28%
FCF growth 1Y-82.04%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-80.67%
OCF growth 3YN/A
OCF growth 5Y22.81%